BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2972696)

  • 1. Psychiatric morbidity associated with early clinical diagnosis of Huntington disease in a predictive testing program.
    Lam RW; Bloch M; Jones BD; Marcus AM; Fox S; Amman W; Hayden MR
    J Clin Psychiatry; 1988 Nov; 49(11):444-7. PubMed ID: 2972696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychosocial aspects in presymptomatic testing for genetic diseases. Experiences after 2 years of counseling in Huntington disease].
    Blomhoff S; Malt U; Weisaeth L
    Tidsskr Nor Laegeforen; 1995 Jan; 115(1):27-9. PubMed ID: 7846655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attitudes of persons at risk for Huntington disease toward predictive testing.
    Kessler S; Field T; Worth L; Mosbarger H
    Am J Med Genet; 1987 Feb; 26(2):259-70. PubMed ID: 2949610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive testing for Huntington disease: I. Description of a pilot project in British Columbia.
    Fox S; Bloch M; Fahy M; Hayden MR
    Am J Med Genet; 1989 Feb; 32(2):211-6. PubMed ID: 2522734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk.
    Huggins M; Bloch M; Wiggins S; Adam S; Suchowersky O; Trew M; Klimek M; Greenberg CR; Eleff M; Thompson LP
    Am J Med Genet; 1992 Feb; 42(4):508-15. PubMed ID: 1535178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Psychosocial consequences of presymptomatic genetic testing. A retrospective study of testing for Huntington disease].
    Jakobsen LB; Malt U; Nilsson B; Rosenlund S; Heiberg A
    Tidsskr Nor Laegeforen; 1999 May; 119(13):1913-6. PubMed ID: 10382341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific psychiatric manifestations among preclinical Huntington disease mutation carriers.
    Marshall J; White K; Weaver M; Flury Wetherill L; Hui S; Stout JC; Johnson SA; Beristain X; Gray J; Wojcieszek J; Foroud T
    Arch Neurol; 2007 Jan; 64(1):116-21. PubMed ID: 17210818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes toward presymptomatic testing in Huntington disease.
    Mastromauro C; Myers RH; Berkman B
    Am J Med Genet; 1987 Feb; 26(2):271-82. PubMed ID: 2949611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive genetic tests in neurodegenerative disorders: a methodological approach integrating psychological counseling for at-risk individuals and referring clinicians.
    Mariotti C; Ferruta A; Gellera C; Nespolo C; Fancellu R; Genitrini S; Di Bella D; Panzeri M; Nanetti L; Tomasello C; Taroni F; Foresti G; Astori S
    Eur Neurol; 2010; 64(1):33-41. PubMed ID: 20588047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for genetic testing in Huntington disease: three years of experience in Minnesota.
    Nance MA; Leroy BS; Orr HT; Parker T; Rich SS; Heston LL
    Am J Med Genet; 1991 Sep; 40(4):518-22. PubMed ID: 1836107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intended use of predictive testing by those at risk for Huntington disease.
    Meissen GJ; Berchek RL
    Am J Med Genet; 1987 Feb; 26(2):283-93. PubMed ID: 2949612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. At-risk persons' attitudes toward presymptomatic and prenatal testing of Huntington disease in Michigan.
    Markel DS; Young AB; Penney JB
    Am J Med Genet; 1987 Feb; 26(2):295-305. PubMed ID: 2949613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of the effects of predictive testing for Huntington disease on intimate relationships.
    Quaid KA; Wesson MK
    Am J Med Genet; 1995 May; 57(1):46-51. PubMed ID: 7645597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of Huntington disease: a model for the stages of psychological response based on experience of a predictive testing program.
    Bloch M; Adam S; Fuller A; Kremer B; Welch JP; Wiggins S; Whyte P; Huggins M; Theilmann J; Hayden MR
    Am J Med Genet; 1993 Sep; 47(3):368-74. PubMed ID: 8135283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic testing and mental health: the model of Huntington disease.
    Williams JK; Schutte DL
    Online J Issues Nurs; 2000; 5(3):3. PubMed ID: 11380269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Huntington disease: presymptomatic testing, prenatal diagnosis, preimplantation genetic diagnosis experience].
    Durr A; Viville S
    Gynecol Obstet Fertil; 2007 Oct; 35(10):1051-4. PubMed ID: 17897866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Results of a program of presymptomatic diagnosis of Huntington's disease: evaluation of a 6 year period].
    Solís-Pérez MP; Burguera JA; Palau F; Livianos L; Vila M; Rojo L
    Neurologia; 2001 Oct; 16(8):348-52. PubMed ID: 11738012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presymptomatic, prenatal, and exclusion testing for Huntington disease using seven closely linked DNA markers.
    Skraastad MI; Verwest A; Bakker E; Vegter-van der Vlis M; van Leeuwen-Cornelisse I; Roos RA; Pearson PL; van Ommen GJ
    Am J Med Genet; 1991 May; 39(2):217-22. PubMed ID: 1829584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological effects of predictive testing for Huntington's disease.
    Hayden MR; Bloch M; Wiggins S
    Adv Neurol; 1995; 65():201-10. PubMed ID: 7872141
    [No Abstract]   [Full Text] [Related]  

  • 20. Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk.
    Bloch M; Adam S; Wiggins S; Huggins M; Hayden MR
    Am J Med Genet; 1992 Feb; 42(4):499-507. PubMed ID: 1535177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.